A first-in-human study of intravenous BAL101553, a novel microtubule inhibitor, in patients with advanced solid tumors

Date 02 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Phase 1 studies: Miscellaneous drugs & targets
Topics Anti-Cancer Agents & Biologic Therapy
Drug Development
Presenter Rhoda Molife